Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Loratadine impurity 33

Loratadine impurity 33 is listed in the pharmaceutical impurity collection under CAS 130642-50-1. Its represented structure has formula C20H23ClN2O and a calculated molecular weight of 342.87 g/mol.

2D chemical structure

N O N C l

Chemical identity

Catalog name
Loratadine impurity 33
Common name
Loratadine impurity 33
Chemical name
[3-[2-(3-chlorophenyl)ethyl]-2-pyridinyl]-(1-methylpiperidin-4-yl)methanone
CAS
130642-50-1
SMILES
CN1CCC(C(=O)c2ncccc2CCc2cccc(Cl)c2)CC1
InChI
InChI=1S/C20H23ClN2O/c1-23-12-9-17(10-13-23)20(24)19-16(5-3-11-22-19)8-7-15-4-2-6-18(21)14-15/h2-6,11,14,17H,7-10,12-13H2,1H3
InChIKey
YBWTYYOASANXND-UHFFFAOYSA-N
Associated API
Loratadine

Record ID: A00f4c71bcca9

Computed properties

C20H23ClN2O Molecular formula
342.87 g/molMolecular weight
342.1499 DaMonoisotopic exact mass
33.2 ŲTopological polar surface area
4.0447 Calculated LogP (Wildman–Crippen)
97.6485 cm³/molMolar refractivity (Wildman–Crippen)
3 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H N O 0 5 10 15 20 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight342.8756.31
Calculated LogP (Wildman–Crippen)4.044779.07
Topological polar surface area33.216.02
Hydrogen-bond acceptors333.13
Hydrogen-bond donors011.28
Rotatable bonds (strict)560.59

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC20H23ClN2Odimensionless
Molecular weight342.87g/mol
Monoisotopic exact mass342.1499Da
Topological polar surface area33.2Ų
Calculated LogP (Wildman–Crippen)4.0447dimensionless
Molar refractivity (Wildman–Crippen)97.6485cm³/mol
Hydrogen-bond acceptors3count
Hydrogen-bond donors0count
Rotatable bonds (strict)5count
Heavy atoms24count
Heteroatoms4count
Rings3count
Aromatic rings2count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles1count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.4fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area148.2114Ų
Valence electrons126count
Radical electrons0count
Bertz complexity708.29index
Balaban J1.715index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Loratadine impurity 33

Qualification and safety assessment of Loratadine impurity 33

Explore toxicological qualification of Loratadine impurity 33 and ICH M7 mutagenic impurity assessment of Loratadine impurity 33 for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Loratadine impurity 33 and acceptable intake and limit justification for Loratadine impurity 33. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Loratadine impurity 33

Explore Altox services and software through the Altox Pharma-Hub.